591 views
Speakers: Nikita Valerievich Lomakin - MD, PhD, Chief Cardiologist of the Presidential Property Management Department of the Russian Federation, Head of the Cardiology Department No. 2, Head of the Cardiology Department of the Russian Medical Academy of Continuous Professional Education of the Russian Ministry of Health Lyudmila Ivanovna Buryachkovskaya - MD, PhD, Leading Researcher of the National Medical Research Center of Cardiology of the Russian Ministry of Health Program: 18:00 - 18:50 - Availability of Modern Anticoagulant Therapy 18:50 - 19:00 - Answers to Questions The webinar will present a study project entitled “A Single-Center Prospective Open-Label Observational Study of the Antiplatelet Effects of Rivaroxaban in High-Risk Patients with IHD”. The study will compare the effectiveness of the domestic Cruoxaban with the original foreign Rivaroxaban. 0:00 Start screen 0:45 Opening remarks 2:20 Lomakin N.V. "Anticoagulant therapy in complex clinical situations" 27:27 Buryachkovskaya L.I. "New possibilities of low doses of rivaroxaban in cardiovascular diseases" 1:00:50 Answers to questions